nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ALB—multiple sclerosis	0.149	1	CbGaD
Methotrexate—ABCC1—Mitoxantrone—multiple sclerosis	0.0579	0.143	CbGbCtD
Methotrexate—ABCG2—Cladribine—multiple sclerosis	0.0531	0.131	CbGbCtD
Methotrexate—SLCO1A2—Prednisolone—multiple sclerosis	0.0454	0.112	CbGbCtD
Methotrexate—SLCO1A2—Prednisone—multiple sclerosis	0.0429	0.106	CbGbCtD
Methotrexate—ABCG2—Mitoxantrone—multiple sclerosis	0.0387	0.0954	CbGbCtD
Methotrexate—SLCO1A2—Dexamethasone—multiple sclerosis	0.0268	0.066	CbGbCtD
Methotrexate—ABCC2—Dexamethasone—multiple sclerosis	0.0222	0.0547	CbGbCtD
Methotrexate—ALB—Prednisone—multiple sclerosis	0.0222	0.0546	CbGbCtD
Methotrexate—ABCG2—Dexamethasone—multiple sclerosis	0.0201	0.0495	CbGbCtD
Methotrexate—ABCB1—Methylprednisolone—multiple sclerosis	0.0191	0.0472	CbGbCtD
Methotrexate—ABCB1—Mitoxantrone—multiple sclerosis	0.014	0.0344	CbGbCtD
Methotrexate—ABCB1—Betamethasone—multiple sclerosis	0.0124	0.0307	CbGbCtD
Methotrexate—ABCB1—Prednisolone—multiple sclerosis	0.0123	0.0303	CbGbCtD
Methotrexate—ABCB1—Prednisone—multiple sclerosis	0.0116	0.0286	CbGbCtD
Methotrexate—ABCB1—Dexamethasone—multiple sclerosis	0.00724	0.0178	CbGbCtD
Methotrexate—ATIC—leg—multiple sclerosis	0.00652	0.0795	CbGeAlD
Methotrexate—ATIC—brainstem—multiple sclerosis	0.00152	0.0185	CbGeAlD
Methotrexate—FPGS—retina—multiple sclerosis	0.00152	0.0185	CbGeAlD
Methotrexate—ATIC—retina—multiple sclerosis	0.00147	0.0179	CbGeAlD
Methotrexate—FOLR1—central nervous system—multiple sclerosis	0.00136	0.0165	CbGeAlD
Methotrexate—FOLR1—cerebellum—multiple sclerosis	0.00133	0.0162	CbGeAlD
Methotrexate—GGH—medulla oblongata—multiple sclerosis	0.00125	0.0152	CbGeAlD
Methotrexate—SLC19A1—nervous system—multiple sclerosis	0.00124	0.0151	CbGeAlD
Methotrexate—SLC19A1—central nervous system—multiple sclerosis	0.00119	0.0145	CbGeAlD
Methotrexate—SLC19A1—cerebellum—multiple sclerosis	0.00116	0.0142	CbGeAlD
Methotrexate—GGH—midbrain—multiple sclerosis	0.00114	0.0139	CbGeAlD
Methotrexate—SLC46A1—spinal cord—multiple sclerosis	0.00113	0.0138	CbGeAlD
Methotrexate—GGH—spinal cord—multiple sclerosis	0.00111	0.0135	CbGeAlD
Methotrexate—FPGS—medulla oblongata—multiple sclerosis	0.0011	0.0134	CbGeAlD
Methotrexate—FOLR1—brain—multiple sclerosis	0.00108	0.0131	CbGeAlD
Methotrexate—SLCO3A1—retina—multiple sclerosis	0.00107	0.0131	CbGeAlD
Methotrexate—DHFR—retina—multiple sclerosis	0.000985	0.012	CbGeAlD
Methotrexate—FPGS—spinal cord—multiple sclerosis	0.000977	0.0119	CbGeAlD
Methotrexate—ATIC—midbrain—multiple sclerosis	0.000969	0.0118	CbGeAlD
Methotrexate—SLC46A1—nervous system—multiple sclerosis	0.000952	0.0116	CbGeAlD
Methotrexate—PGD—retina—multiple sclerosis	0.000947	0.0115	CbGeAlD
Methotrexate—ATIC—spinal cord—multiple sclerosis	0.000945	0.0115	CbGeAlD
Methotrexate—SLC19A1—brain—multiple sclerosis	0.000945	0.0115	CbGeAlD
Methotrexate—GGH—nervous system—multiple sclerosis	0.000937	0.0114	CbGeAlD
Methotrexate—SLC46A1—central nervous system—multiple sclerosis	0.000917	0.0112	CbGeAlD
Methotrexate—GGH—central nervous system—multiple sclerosis	0.000902	0.011	CbGeAlD
Methotrexate—SLC46A1—cerebellum—multiple sclerosis	0.000896	0.0109	CbGeAlD
Methotrexate—SLC16A1—retina—multiple sclerosis	0.000884	0.0108	CbGeAlD
Methotrexate—GGH—cerebellum—multiple sclerosis	0.000882	0.0107	CbGeAlD
Methotrexate—FPGS—nervous system—multiple sclerosis	0.000824	0.01	CbGeAlD
Methotrexate—SLCO1C1—midbrain—multiple sclerosis	0.000806	0.00982	CbGeAlD
Methotrexate—ATIC—nervous system—multiple sclerosis	0.000797	0.00971	CbGeAlD
Methotrexate—FPGS—central nervous system—multiple sclerosis	0.000793	0.00966	CbGeAlD
Methotrexate—SLCO1C1—spinal cord—multiple sclerosis	0.000786	0.00958	CbGeAlD
Methotrexate—SLCO3A1—medulla oblongata—multiple sclerosis	0.000775	0.00945	CbGeAlD
Methotrexate—FPGS—cerebellum—multiple sclerosis	0.000775	0.00944	CbGeAlD
Methotrexate—ATIC—central nervous system—multiple sclerosis	0.000767	0.00934	CbGeAlD
Methotrexate—ATIC—cerebellum—multiple sclerosis	0.00075	0.00913	CbGeAlD
Methotrexate—SLC46A1—brain—multiple sclerosis	0.000728	0.00887	CbGeAlD
Methotrexate—GGH—brain—multiple sclerosis	0.000716	0.00873	CbGeAlD
Methotrexate—DHFR—medulla oblongata—multiple sclerosis	0.000712	0.00867	CbGeAlD
Methotrexate—SLCO3A1—midbrain—multiple sclerosis	0.000709	0.00863	CbGeAlD
Methotrexate—SLCO3A1—spinal cord—multiple sclerosis	0.000691	0.00842	CbGeAlD
Methotrexate—PGD—medulla oblongata—multiple sclerosis	0.000684	0.00834	CbGeAlD
Methotrexate—SLCO1C1—nervous system—multiple sclerosis	0.000662	0.00807	CbGeAlD
Methotrexate—TYMS—midbrain—multiple sclerosis	0.000657	0.00801	CbGeAlD
Methotrexate—DHFR—midbrain—multiple sclerosis	0.000651	0.00793	CbGeAlD
Methotrexate—SLC16A1—medulla oblongata—multiple sclerosis	0.000639	0.00779	CbGeAlD
Methotrexate—SLCO1C1—central nervous system—multiple sclerosis	0.000638	0.00777	CbGeAlD
Methotrexate—DHFR—spinal cord—multiple sclerosis	0.000635	0.00773	CbGeAlD
Methotrexate—FPGS—brain—multiple sclerosis	0.00063	0.00767	CbGeAlD
Methotrexate—PGD—midbrain—multiple sclerosis	0.000626	0.00762	CbGeAlD
Methotrexate—PGD—spinal cord—multiple sclerosis	0.00061	0.00744	CbGeAlD
Methotrexate—ATIC—brain—multiple sclerosis	0.000609	0.00742	CbGeAlD
Methotrexate—MTHFR—nervous system—multiple sclerosis	0.000592	0.00721	CbGeAlD
Methotrexate—ABCC10—medulla oblongata—multiple sclerosis	0.000587	0.00715	CbGeAlD
Methotrexate—SLC16A1—midbrain—multiple sclerosis	0.000584	0.00712	CbGeAlD
Methotrexate—SLCO3A1—nervous system—multiple sclerosis	0.000583	0.0071	CbGeAlD
Methotrexate—MTHFR—central nervous system—multiple sclerosis	0.00057	0.00695	CbGeAlD
Methotrexate—SLC16A1—spinal cord—multiple sclerosis	0.00057	0.00694	CbGeAlD
Methotrexate—SLCO3A1—central nervous system—multiple sclerosis	0.000561	0.00683	CbGeAlD
Methotrexate—MTHFR—cerebellum—multiple sclerosis	0.000557	0.00679	CbGeAlD
Methotrexate—SLCO3A1—cerebellum—multiple sclerosis	0.000548	0.00668	CbGeAlD
Methotrexate—TYMS—nervous system—multiple sclerosis	0.00054	0.00658	CbGeAlD
Methotrexate—ABCC10—midbrain—multiple sclerosis	0.000536	0.00654	CbGeAlD
Methotrexate—DHFR—nervous system—multiple sclerosis	0.000535	0.00652	CbGeAlD
Methotrexate—ABCC10—spinal cord—multiple sclerosis	0.000523	0.00638	CbGeAlD
Methotrexate—TYMS—central nervous system—multiple sclerosis	0.00052	0.00634	CbGeAlD
Methotrexate—DHFR—central nervous system—multiple sclerosis	0.000515	0.00627	CbGeAlD
Methotrexate—PGD—nervous system—multiple sclerosis	0.000514	0.00627	CbGeAlD
Methotrexate—TYMS—cerebellum—multiple sclerosis	0.000508	0.00619	CbGeAlD
Methotrexate—SLCO1C1—brain—multiple sclerosis	0.000506	0.00617	CbGeAlD
Methotrexate—SLCO1A2—medulla oblongata—multiple sclerosis	0.000506	0.00616	CbGeAlD
Methotrexate—DHFR—cerebellum—multiple sclerosis	0.000503	0.00613	CbGeAlD
Methotrexate—PGD—central nervous system—multiple sclerosis	0.000495	0.00603	CbGeAlD
Methotrexate—PGD—cerebellum—multiple sclerosis	0.000484	0.0059	CbGeAlD
Methotrexate—SLC16A1—nervous system—multiple sclerosis	0.00048	0.00585	CbGeAlD
Methotrexate—SLC22A7—brain—multiple sclerosis	0.00048	0.00585	CbGeAlD
Methotrexate—SLC22A6—brain—multiple sclerosis	0.000463	0.00565	CbGeAlD
Methotrexate—SLCO1A2—midbrain—multiple sclerosis	0.000462	0.00563	CbGeAlD
Methotrexate—SLC16A1—central nervous system—multiple sclerosis	0.000462	0.00563	CbGeAlD
Methotrexate—MTHFR—brain—multiple sclerosis	0.000453	0.00551	CbGeAlD
Methotrexate—SLC16A1—cerebellum—multiple sclerosis	0.000452	0.0055	CbGeAlD
Methotrexate—SLCO1A2—spinal cord—multiple sclerosis	0.000451	0.0055	CbGeAlD
Methotrexate—SLCO3A1—brain—multiple sclerosis	0.000445	0.00543	CbGeAlD
Methotrexate—ABCC3—nervous system—multiple sclerosis	0.000443	0.0054	CbGeAlD
Methotrexate—ABCC3—central nervous system—multiple sclerosis	0.000427	0.0052	CbGeAlD
Methotrexate—AOX1—cerebellum—multiple sclerosis	0.000426	0.00519	CbGeAlD
Methotrexate—ABCC10—cerebellum—multiple sclerosis	0.000415	0.00506	CbGeAlD
Methotrexate—TYMS—brain—multiple sclerosis	0.000413	0.00503	CbGeAlD
Methotrexate—DHFR—brain—multiple sclerosis	0.000409	0.00498	CbGeAlD
Methotrexate—PGD—brain—multiple sclerosis	0.000393	0.00479	CbGeAlD
Methotrexate—SLCO1A2—nervous system—multiple sclerosis	0.00038	0.00463	CbGeAlD
Methotrexate—SLC16A1—brain—multiple sclerosis	0.000367	0.00447	CbGeAlD
Methotrexate—SLCO1A2—central nervous system—multiple sclerosis	0.000366	0.00446	CbGeAlD
Methotrexate—ABCC4—nervous system—multiple sclerosis	0.000366	0.00446	CbGeAlD
Methotrexate—SLC22A8—nervous system—multiple sclerosis	0.000363	0.00442	CbGeAlD
Methotrexate—SLCO1A2—cerebellum—multiple sclerosis	0.000358	0.00436	CbGeAlD
Methotrexate—ABCC4—central nervous system—multiple sclerosis	0.000352	0.00429	CbGeAlD
Methotrexate—SLC22A8—central nervous system—multiple sclerosis	0.000349	0.00426	CbGeAlD
Methotrexate—AOX1—brain—multiple sclerosis	0.000346	0.00422	CbGeAlD
Methotrexate—ABCG2—medulla oblongata—multiple sclerosis	0.000344	0.00419	CbGeAlD
Methotrexate—ABCC3—brain—multiple sclerosis	0.000339	0.00413	CbGeAlD
Methotrexate—ABCC10—brain—multiple sclerosis	0.000337	0.00411	CbGeAlD
Methotrexate—ABCG2—midbrain—multiple sclerosis	0.000314	0.00383	CbGeAlD
Methotrexate—ABCG2—spinal cord—multiple sclerosis	0.000306	0.00373	CbGeAlD
Methotrexate—ABCC1—cerebellum—multiple sclerosis	0.000293	0.00358	CbGeAlD
Methotrexate—SLCO1A2—brain—multiple sclerosis	0.00029	0.00354	CbGeAlD
Methotrexate—ALB—brain—multiple sclerosis	0.000289	0.00352	CbGeAlD
Methotrexate—ABCC4—brain—multiple sclerosis	0.00028	0.00341	CbGeAlD
Methotrexate—SLC22A8—brain—multiple sclerosis	0.000277	0.00338	CbGeAlD
Methotrexate—ABCG2—cerebellum—multiple sclerosis	0.000243	0.00296	CbGeAlD
Methotrexate—ABCC1—brain—multiple sclerosis	0.000238	0.0029	CbGeAlD
Methotrexate—ABCB1—retina—multiple sclerosis	0.000234	0.00286	CbGeAlD
Methotrexate—ABCG2—brain—multiple sclerosis	0.000197	0.0024	CbGeAlD
Methotrexate—TYMS—Azacitidine—Cladribine—multiple sclerosis	0.000193	0.0491	CbGdCrCtD
Methotrexate—ABCB1—medulla oblongata—multiple sclerosis	0.000169	0.00206	CbGeAlD
Methotrexate—ABCB1—midbrain—multiple sclerosis	0.000155	0.00189	CbGeAlD
Methotrexate—ABCB1—spinal cord—multiple sclerosis	0.000151	0.00184	CbGeAlD
Methotrexate—ABCB1—nervous system—multiple sclerosis	0.000127	0.00155	CbGeAlD
Methotrexate—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.000124	0.0315	CbGdCrCtD
Methotrexate—ABCB1—central nervous system—multiple sclerosis	0.000123	0.00149	CbGeAlD
Methotrexate—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	0.000122	0.0311	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.000122	0.031	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	0.000122	0.031	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	0.000121	0.0308	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	0.00012	0.0306	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Betamethasone—multiple sclerosis	0.00012	0.0306	CbGdCrCtD
Methotrexate—ABCB1—cerebellum—multiple sclerosis	0.00012	0.00146	CbGeAlD
Methotrexate—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.000119	0.0303	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	0.000119	0.0303	CbGdCrCtD
Methotrexate—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	0.000119	0.0303	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000118	0.03	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	0.000118	0.0299	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000116	0.0295	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000116	0.0295	CbGdCrCtD
Methotrexate—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000114	0.0289	CbGdCrCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	0.000113	0.0288	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Prednisone—multiple sclerosis	0.000112	0.0284	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	0.000112	0.0284	CbGdCrCtD
Methotrexate—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000112	0.00044	CcSEcCtD
Methotrexate—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000111	0.000439	CcSEcCtD
Methotrexate—Anorexia—Mitoxantrone—multiple sclerosis	0.000111	0.000438	CcSEcCtD
Methotrexate—Headache—Cladribine—multiple sclerosis	0.000111	0.000438	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisone—multiple sclerosis	0.000111	0.0281	CbGdCrCtD
Methotrexate—Vision blurred—Prednisolone—multiple sclerosis	0.00011	0.000435	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00011	0.0281	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	0.00011	0.0279	CbGdCrCtD
Methotrexate—TYMS—Diflorasone—Betamethasone—multiple sclerosis	0.00011	0.0279	CbGdCrCtD
Methotrexate—TYMS—Flunisolide—Prednisolone—multiple sclerosis	0.000109	0.0277	CbGdCrCtD
Methotrexate—Hypotension—Mitoxantrone—multiple sclerosis	0.000109	0.000429	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000109	0.000429	CcSEcCtD
Methotrexate—Depression—Prednisone—multiple sclerosis	0.000109	0.000428	CcSEcCtD
Methotrexate—Visual impairment—Betamethasone—multiple sclerosis	0.000108	0.000427	CcSEcCtD
Methotrexate—Visual impairment—Dexamethasone—multiple sclerosis	0.000108	0.000427	CcSEcCtD
Methotrexate—Mental disorder—Methylprednisolone—multiple sclerosis	0.000108	0.000427	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	0.000108	0.0274	CbGdCrCtD
Methotrexate—Erythema—Triamcinolone—multiple sclerosis	0.000108	0.000425	CcSEcCtD
Methotrexate—Erythema—Methylprednisolone—multiple sclerosis	0.000108	0.000424	CcSEcCtD
Methotrexate—Malnutrition—Methylprednisolone—multiple sclerosis	0.000108	0.000424	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	0.000107	0.0273	CbGdCrCtD
Methotrexate—Hypersensitivity—Azathioprine—multiple sclerosis	0.000106	0.000419	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000106	0.000419	CcSEcCtD
Methotrexate—Malaise—Prednisolone—multiple sclerosis	0.000106	0.000417	CcSEcCtD
Methotrexate—Dysgeusia—Triamcinolone—multiple sclerosis	0.000106	0.000416	CcSEcCtD
Methotrexate—Nausea—Cladribine—multiple sclerosis	0.000105	0.000415	CcSEcCtD
Methotrexate—Vertigo—Prednisolone—multiple sclerosis	0.000105	0.000415	CcSEcCtD
Methotrexate—Eye disorder—Dexamethasone—multiple sclerosis	0.000105	0.000414	CcSEcCtD
Methotrexate—Eye disorder—Betamethasone—multiple sclerosis	0.000105	0.000414	CcSEcCtD
Methotrexate—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000105	0.000413	CcSEcCtD
Methotrexate—Back pain—Triamcinolone—multiple sclerosis	0.000104	0.000411	CcSEcCtD
Methotrexate—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000104	0.00041	CcSEcCtD
Methotrexate—Somnolence—Mitoxantrone—multiple sclerosis	0.000104	0.000408	CcSEcCtD
Methotrexate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000103	0.000404	CcSEcCtD
Methotrexate—Angiopathy—Dexamethasone—multiple sclerosis	0.000102	0.000402	CcSEcCtD
Methotrexate—Angiopathy—Betamethasone—multiple sclerosis	0.000102	0.000402	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisone—multiple sclerosis	0.000102	0.0259	CbGdCrCtD
Methotrexate—Convulsion—Prednisolone—multiple sclerosis	0.000102	0.0004	CcSEcCtD
Methotrexate—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000101	0.000399	CcSEcCtD
Methotrexate—Fatigue—Mitoxantrone—multiple sclerosis	0.000101	0.000396	CcSEcCtD
Methotrexate—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.0001	0.000394	CcSEcCtD
Methotrexate—Ill-defined disorder—Methylprednisolone—multiple sclerosis	9.98e-05	0.000393	CcSEcCtD
Methotrexate—Pain—Mitoxantrone—multiple sclerosis	9.97e-05	0.000393	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisolone—multiple sclerosis	9.95e-05	0.0253	CbGdCrCtD
Methotrexate—Alopecia—Dexamethasone—multiple sclerosis	9.93e-05	0.000391	CcSEcCtD
Methotrexate—Alopecia—Betamethasone—multiple sclerosis	9.93e-05	0.000391	CcSEcCtD
Methotrexate—Diarrhoea—Azathioprine—multiple sclerosis	9.87e-05	0.000389	CcSEcCtD
Methotrexate—Discomfort—Prednisolone—multiple sclerosis	9.86e-05	0.000389	CcSEcCtD
Methotrexate—Haemoglobin—Prednisone—multiple sclerosis	9.83e-05	0.000388	CcSEcCtD
Methotrexate—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	9.79e-05	0.0249	CbGdCrCtD
Methotrexate—Haemorrhage—Prednisone—multiple sclerosis	9.78e-05	0.000386	CcSEcCtD
Methotrexate—Erythema—Dexamethasone—multiple sclerosis	9.78e-05	0.000385	CcSEcCtD
Methotrexate—Erythema—Betamethasone—multiple sclerosis	9.78e-05	0.000385	CcSEcCtD
Methotrexate—ABCB1—brain—multiple sclerosis	9.73e-05	0.00119	CbGeAlD
Methotrexate—Malaise—Triamcinolone—multiple sclerosis	9.72e-05	0.000383	CcSEcCtD
Methotrexate—Malaise—Methylprednisolone—multiple sclerosis	9.7e-05	0.000382	CcSEcCtD
Methotrexate—Vertigo—Triamcinolone—multiple sclerosis	9.68e-05	0.000382	CcSEcCtD
Methotrexate—Vertigo—Methylprednisolone—multiple sclerosis	9.66e-05	0.000381	CcSEcCtD
Methotrexate—TYMS—Budesonide—Dexamethasone—multiple sclerosis	9.63e-05	0.0245	CbGdCrCtD
Methotrexate—TYMS—Budesonide—Betamethasone—multiple sclerosis	9.63e-05	0.0245	CbGdCrCtD
Methotrexate—Feeling abnormal—Mitoxantrone—multiple sclerosis	9.61e-05	0.000379	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisolone—multiple sclerosis	9.57e-05	0.000377	CcSEcCtD
Methotrexate—Dizziness—Azathioprine—multiple sclerosis	9.54e-05	0.000376	CcSEcCtD
Methotrexate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	9.54e-05	0.000376	CcSEcCtD
Methotrexate—TYMS—Budesonide—Triamcinolone—multiple sclerosis	9.41e-05	0.0239	CbGdCrCtD
Methotrexate—Cough—Triamcinolone—multiple sclerosis	9.41e-05	0.000371	CcSEcCtD
Methotrexate—Convulsion—Triamcinolone—multiple sclerosis	9.34e-05	0.000368	CcSEcCtD
Methotrexate—Convulsion—Methylprednisolone—multiple sclerosis	9.32e-05	0.000367	CcSEcCtD
Methotrexate—Urticaria—Mitoxantrone—multiple sclerosis	9.26e-05	0.000365	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisolone—multiple sclerosis	9.25e-05	0.000364	CcSEcCtD
Methotrexate—Body temperature increased—Mitoxantrone—multiple sclerosis	9.22e-05	0.000363	CcSEcCtD
Methotrexate—Abdominal pain—Mitoxantrone—multiple sclerosis	9.22e-05	0.000363	CcSEcCtD
Methotrexate—Myalgia—Triamcinolone—multiple sclerosis	9.18e-05	0.000362	CcSEcCtD
Methotrexate—Vomiting—Azathioprine—multiple sclerosis	9.17e-05	0.000361	CcSEcCtD
Methotrexate—Myalgia—Methylprednisolone—multiple sclerosis	9.16e-05	0.000361	CcSEcCtD
Methotrexate—Arthralgia—Methylprednisolone—multiple sclerosis	9.16e-05	0.000361	CcSEcCtD
Methotrexate—Eye disorder—Prednisone—multiple sclerosis	9.14e-05	0.00036	CcSEcCtD
Methotrexate—Rash—Azathioprine—multiple sclerosis	9.09e-05	0.000358	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	9.09e-05	0.000358	CcSEcCtD
Methotrexate—Dermatitis—Azathioprine—multiple sclerosis	9.09e-05	0.000358	CcSEcCtD
Methotrexate—Ill-defined disorder—Betamethasone—multiple sclerosis	9.08e-05	0.000358	CcSEcCtD
Methotrexate—Ill-defined disorder—Dexamethasone—multiple sclerosis	9.08e-05	0.000358	CcSEcCtD
Methotrexate—Discomfort—Triamcinolone—multiple sclerosis	9.07e-05	0.000357	CcSEcCtD
Methotrexate—Discomfort—Methylprednisolone—multiple sclerosis	9.05e-05	0.000356	CcSEcCtD
Methotrexate—Headache—Azathioprine—multiple sclerosis	9.04e-05	0.000356	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisone—multiple sclerosis	8.93e-05	0.0227	CbGdCrCtD
Methotrexate—Angiopathy—Prednisone—multiple sclerosis	8.88e-05	0.00035	CcSEcCtD
Methotrexate—Confusional state—Methylprednisolone—multiple sclerosis	8.85e-05	0.000349	CcSEcCtD
Methotrexate—Immune system disorder—Prednisone—multiple sclerosis	8.84e-05	0.000348	CcSEcCtD
Methotrexate—Malaise—Dexamethasone—multiple sclerosis	8.82e-05	0.000348	CcSEcCtD
Methotrexate—Malaise—Betamethasone—multiple sclerosis	8.82e-05	0.000348	CcSEcCtD
Methotrexate—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.8e-05	0.000347	CcSEcCtD
Methotrexate—Vertigo—Dexamethasone—multiple sclerosis	8.79e-05	0.000346	CcSEcCtD
Methotrexate—Vertigo—Betamethasone—multiple sclerosis	8.79e-05	0.000346	CcSEcCtD
Methotrexate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.78e-05	0.000346	CcSEcCtD
Methotrexate—Infection—Triamcinolone—multiple sclerosis	8.74e-05	0.000344	CcSEcCtD
Methotrexate—Infection—Methylprednisolone—multiple sclerosis	8.72e-05	0.000344	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisolone—multiple sclerosis	8.72e-05	0.0222	CbGdCrCtD
Methotrexate—Insomnia—Prednisolone—multiple sclerosis	8.65e-05	0.000341	CcSEcCtD
Methotrexate—Alopecia—Prednisone—multiple sclerosis	8.65e-05	0.000341	CcSEcCtD
Methotrexate—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.61e-05	0.000339	CcSEcCtD
Methotrexate—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.59e-05	0.000339	CcSEcCtD
Methotrexate—Paraesthesia—Prednisolone—multiple sclerosis	8.59e-05	0.000338	CcSEcCtD
Methotrexate—Mental disorder—Prednisone—multiple sclerosis	8.57e-05	0.000338	CcSEcCtD
Methotrexate—Nausea—Azathioprine—multiple sclerosis	8.57e-05	0.000338	CcSEcCtD
Methotrexate—TYMS—Danazol—Prednisone—multiple sclerosis	8.56e-05	0.0218	CbGdCrCtD
Methotrexate—Skin disorder—Methylprednisolone—multiple sclerosis	8.53e-05	0.000336	CcSEcCtD
Methotrexate—Malnutrition—Prednisone—multiple sclerosis	8.52e-05	0.000336	CcSEcCtD
Methotrexate—Erythema—Prednisone—multiple sclerosis	8.52e-05	0.000336	CcSEcCtD
Methotrexate—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.5e-05	0.000335	CcSEcCtD
Methotrexate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.49e-05	0.000334	CcSEcCtD
Methotrexate—Convulsion—Dexamethasone—multiple sclerosis	8.47e-05	0.000334	CcSEcCtD
Methotrexate—Convulsion—Betamethasone—multiple sclerosis	8.47e-05	0.000334	CcSEcCtD
Methotrexate—Asthenia—Mitoxantrone—multiple sclerosis	8.37e-05	0.00033	CcSEcCtD
Methotrexate—Myalgia—Betamethasone—multiple sclerosis	8.33e-05	0.000328	CcSEcCtD
Methotrexate—Myalgia—Dexamethasone—multiple sclerosis	8.33e-05	0.000328	CcSEcCtD
Methotrexate—Discomfort—Betamethasone—multiple sclerosis	8.23e-05	0.000324	CcSEcCtD
Methotrexate—Discomfort—Dexamethasone—multiple sclerosis	8.23e-05	0.000324	CcSEcCtD
Methotrexate—Hypotension—Methylprednisolone—multiple sclerosis	8.2e-05	0.000323	CcSEcCtD
Methotrexate—Pain—Prednisolone—multiple sclerosis	8.18e-05	0.000322	CcSEcCtD
Methotrexate—Vision blurred—Prednisone—multiple sclerosis	8.03e-05	0.000316	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	8.02e-05	0.000316	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	8e-05	0.000315	CcSEcCtD
Methotrexate—Anaphylactic shock—Betamethasone—multiple sclerosis	7.98e-05	0.000315	CcSEcCtD
Methotrexate—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.98e-05	0.000315	CcSEcCtD
Methotrexate—Diarrhoea—Mitoxantrone—multiple sclerosis	7.98e-05	0.000314	CcSEcCtD
Methotrexate—Insomnia—Triamcinolone—multiple sclerosis	7.96e-05	0.000314	CcSEcCtD
Methotrexate—Insomnia—Methylprednisolone—multiple sclerosis	7.94e-05	0.000313	CcSEcCtD
Methotrexate—Infection—Dexamethasone—multiple sclerosis	7.93e-05	0.000312	CcSEcCtD
Methotrexate—Infection—Betamethasone—multiple sclerosis	7.93e-05	0.000312	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisone—multiple sclerosis	7.9e-05	0.000311	CcSEcCtD
Methotrexate—Paraesthesia—Triamcinolone—multiple sclerosis	7.9e-05	0.000311	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisolone—multiple sclerosis	7.88e-05	0.000311	CcSEcCtD
Methotrexate—Paraesthesia—Methylprednisolone—multiple sclerosis	7.88e-05	0.000311	CcSEcCtD
Methotrexate—Anaemia—Prednisone—multiple sclerosis	7.87e-05	0.00031	CcSEcCtD
Methotrexate—Dyspnoea—Triamcinolone—multiple sclerosis	7.84e-05	0.000309	CcSEcCtD
Methotrexate—Nervous system disorder—Betamethasone—multiple sclerosis	7.83e-05	0.000308	CcSEcCtD
Methotrexate—Nervous system disorder—Dexamethasone—multiple sclerosis	7.83e-05	0.000308	CcSEcCtD
Methotrexate—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.82e-05	0.000308	CcSEcCtD
Methotrexate—Thrombocytopenia—Betamethasone—multiple sclerosis	7.82e-05	0.000308	CcSEcCtD
Methotrexate—Dyspepsia—Triamcinolone—multiple sclerosis	7.74e-05	0.000305	CcSEcCtD
Methotrexate—Dyspepsia—Methylprednisolone—multiple sclerosis	7.73e-05	0.000304	CcSEcCtD
Methotrexate—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.72e-05	0.000304	CcSEcCtD
Methotrexate—Hyperhidrosis—Betamethasone—multiple sclerosis	7.72e-05	0.000304	CcSEcCtD
Methotrexate—Malaise—Prednisone—multiple sclerosis	7.68e-05	0.000303	CcSEcCtD
Methotrexate—Vertigo—Prednisone—multiple sclerosis	7.65e-05	0.000302	CcSEcCtD
Methotrexate—Anorexia—Betamethasone—multiple sclerosis	7.61e-05	0.0003	CcSEcCtD
Methotrexate—Anorexia—Dexamethasone—multiple sclerosis	7.61e-05	0.0003	CcSEcCtD
Methotrexate—Urticaria—Prednisolone—multiple sclerosis	7.6e-05	0.000299	CcSEcCtD
Methotrexate—Fatigue—Triamcinolone—multiple sclerosis	7.58e-05	0.000299	CcSEcCtD
Methotrexate—Fatigue—Methylprednisolone—multiple sclerosis	7.57e-05	0.000298	CcSEcCtD
Methotrexate—Pain—Triamcinolone—multiple sclerosis	7.52e-05	0.000296	CcSEcCtD
Methotrexate—Hypotension—Betamethasone—multiple sclerosis	7.46e-05	0.000294	CcSEcCtD
Methotrexate—Hypotension—Dexamethasone—multiple sclerosis	7.46e-05	0.000294	CcSEcCtD
Methotrexate—Vomiting—Mitoxantrone—multiple sclerosis	7.41e-05	0.000292	CcSEcCtD
Methotrexate—Convulsion—Prednisone—multiple sclerosis	7.38e-05	0.000291	CcSEcCtD
Methotrexate—Rash—Mitoxantrone—multiple sclerosis	7.35e-05	0.00029	CcSEcCtD
Methotrexate—Dermatitis—Mitoxantrone—multiple sclerosis	7.35e-05	0.000289	CcSEcCtD
Methotrexate—Headache—Mitoxantrone—multiple sclerosis	7.31e-05	0.000288	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.27e-05	0.000287	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.27e-05	0.000287	CcSEcCtD
Methotrexate—Arthralgia—Prednisone—multiple sclerosis	7.25e-05	0.000286	CcSEcCtD
Methotrexate—Myalgia—Prednisone—multiple sclerosis	7.25e-05	0.000286	CcSEcCtD
Methotrexate—Feeling abnormal—Triamcinolone—multiple sclerosis	7.25e-05	0.000286	CcSEcCtD
Methotrexate—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.23e-05	0.000285	CcSEcCtD
Methotrexate—Insomnia—Betamethasone—multiple sclerosis	7.22e-05	0.000284	CcSEcCtD
Methotrexate—Insomnia—Dexamethasone—multiple sclerosis	7.22e-05	0.000284	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	7.2e-05	0.000284	CcSEcCtD
Methotrexate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	7.18e-05	0.000283	CcSEcCtD
Methotrexate—Paraesthesia—Betamethasone—multiple sclerosis	7.17e-05	0.000282	CcSEcCtD
Methotrexate—Paraesthesia—Dexamethasone—multiple sclerosis	7.17e-05	0.000282	CcSEcCtD
Methotrexate—Discomfort—Prednisone—multiple sclerosis	7.16e-05	0.000282	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisolone—multiple sclerosis	7.05e-05	0.000278	CcSEcCtD
Methotrexate—Dyspepsia—Dexamethasone—multiple sclerosis	7.03e-05	0.000277	CcSEcCtD
Methotrexate—Dyspepsia—Betamethasone—multiple sclerosis	7.03e-05	0.000277	CcSEcCtD
Methotrexate—Urticaria—Triamcinolone—multiple sclerosis	6.99e-05	0.000275	CcSEcCtD
Methotrexate—Urticaria—Methylprednisolone—multiple sclerosis	6.97e-05	0.000275	CcSEcCtD
Methotrexate—Body temperature increased—Triamcinolone—multiple sclerosis	6.95e-05	0.000274	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisone—multiple sclerosis	6.95e-05	0.000274	CcSEcCtD
Methotrexate—Abdominal pain—Methylprednisolone—multiple sclerosis	6.94e-05	0.000273	CcSEcCtD
Methotrexate—Decreased appetite—Dexamethasone—multiple sclerosis	6.94e-05	0.000273	CcSEcCtD
Methotrexate—Decreased appetite—Betamethasone—multiple sclerosis	6.94e-05	0.000273	CcSEcCtD
Methotrexate—Nausea—Mitoxantrone—multiple sclerosis	6.93e-05	0.000273	CcSEcCtD
Methotrexate—Infection—Prednisone—multiple sclerosis	6.91e-05	0.000272	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.89e-05	0.000272	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.89e-05	0.000272	CcSEcCtD
Methotrexate—Fatigue—Betamethasone—multiple sclerosis	6.88e-05	0.000271	CcSEcCtD
Methotrexate—Fatigue—Dexamethasone—multiple sclerosis	6.88e-05	0.000271	CcSEcCtD
Methotrexate—Pain—Dexamethasone—multiple sclerosis	6.83e-05	0.000269	CcSEcCtD
Methotrexate—Pain—Betamethasone—multiple sclerosis	6.83e-05	0.000269	CcSEcCtD
Methotrexate—Nervous system disorder—Prednisone—multiple sclerosis	6.82e-05	0.000269	CcSEcCtD
Methotrexate—Skin disorder—Prednisone—multiple sclerosis	6.75e-05	0.000266	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisone—multiple sclerosis	6.72e-05	0.000265	CcSEcCtD
Methotrexate—Anorexia—Prednisone—multiple sclerosis	6.63e-05	0.000261	CcSEcCtD
Methotrexate—Feeling abnormal—Betamethasone—multiple sclerosis	6.58e-05	0.000259	CcSEcCtD
Methotrexate—Feeling abnormal—Dexamethasone—multiple sclerosis	6.58e-05	0.000259	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.53e-05	0.000257	CcSEcCtD
Methotrexate—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.53e-05	0.000257	CcSEcCtD
Methotrexate—Hypersensitivity—Triamcinolone—multiple sclerosis	6.48e-05	0.000255	CcSEcCtD
Methotrexate—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.47e-05	0.000255	CcSEcCtD
Methotrexate—Urticaria—Betamethasone—multiple sclerosis	6.34e-05	0.00025	CcSEcCtD
Methotrexate—Urticaria—Dexamethasone—multiple sclerosis	6.34e-05	0.00025	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.33e-05	0.00025	CcSEcCtD
Methotrexate—Dizziness—Prednisolone—multiple sclerosis	6.33e-05	0.000249	CcSEcCtD
Methotrexate—Asthenia—Triamcinolone—multiple sclerosis	6.31e-05	0.000249	CcSEcCtD
Methotrexate—Abdominal pain—Dexamethasone—multiple sclerosis	6.31e-05	0.000249	CcSEcCtD
Methotrexate—Abdominal pain—Betamethasone—multiple sclerosis	6.31e-05	0.000249	CcSEcCtD
Methotrexate—Body temperature increased—Dexamethasone—multiple sclerosis	6.31e-05	0.000249	CcSEcCtD
Methotrexate—Body temperature increased—Betamethasone—multiple sclerosis	6.31e-05	0.000249	CcSEcCtD
Methotrexate—Asthenia—Methylprednisolone—multiple sclerosis	6.3e-05	0.000248	CcSEcCtD
Methotrexate—Insomnia—Prednisone—multiple sclerosis	6.29e-05	0.000248	CcSEcCtD
Methotrexate—Paraesthesia—Prednisone—multiple sclerosis	6.24e-05	0.000246	CcSEcCtD
Methotrexate—Pruritus—Triamcinolone—multiple sclerosis	6.22e-05	0.000245	CcSEcCtD
Methotrexate—Pruritus—Methylprednisolone—multiple sclerosis	6.21e-05	0.000245	CcSEcCtD
Methotrexate—Dyspepsia—Prednisone—multiple sclerosis	6.12e-05	0.000241	CcSEcCtD
Methotrexate—Decreased appetite—Prednisone—multiple sclerosis	6.04e-05	0.000238	CcSEcCtD
Methotrexate—Rash—Prednisolone—multiple sclerosis	6.03e-05	0.000238	CcSEcCtD
Methotrexate—Dermatitis—Prednisolone—multiple sclerosis	6.03e-05	0.000237	CcSEcCtD
Methotrexate—Diarrhoea—Methylprednisolone—multiple sclerosis	6.01e-05	0.000237	CcSEcCtD
Methotrexate—Fatigue—Prednisone—multiple sclerosis	5.99e-05	0.000236	CcSEcCtD
Methotrexate—Headache—Prednisolone—multiple sclerosis	5.99e-05	0.000236	CcSEcCtD
Methotrexate—Dizziness—Triamcinolone—multiple sclerosis	5.82e-05	0.000229	CcSEcCtD
Methotrexate—Dizziness—Methylprednisolone—multiple sclerosis	5.8e-05	0.000229	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisone—multiple sclerosis	5.73e-05	0.000226	CcSEcCtD
Methotrexate—Asthenia—Betamethasone—multiple sclerosis	5.73e-05	0.000226	CcSEcCtD
Methotrexate—Asthenia—Dexamethasone—multiple sclerosis	5.73e-05	0.000226	CcSEcCtD
Methotrexate—Gastrointestinal pain—Prednisone—multiple sclerosis	5.68e-05	0.000224	CcSEcCtD
Methotrexate—Nausea—Prednisolone—multiple sclerosis	5.68e-05	0.000224	CcSEcCtD
Methotrexate—Pruritus—Betamethasone—multiple sclerosis	5.65e-05	0.000223	CcSEcCtD
Methotrexate—Pruritus—Dexamethasone—multiple sclerosis	5.65e-05	0.000223	CcSEcCtD
Methotrexate—Vomiting—Triamcinolone—multiple sclerosis	5.59e-05	0.00022	CcSEcCtD
Methotrexate—Vomiting—Methylprednisolone—multiple sclerosis	5.58e-05	0.00022	CcSEcCtD
Methotrexate—Rash—Triamcinolone—multiple sclerosis	5.55e-05	0.000219	CcSEcCtD
Methotrexate—Dermatitis—Triamcinolone—multiple sclerosis	5.54e-05	0.000218	CcSEcCtD
Methotrexate—Rash—Methylprednisolone—multiple sclerosis	5.53e-05	0.000218	CcSEcCtD
Methotrexate—Dermatitis—Methylprednisolone—multiple sclerosis	5.53e-05	0.000218	CcSEcCtD
Methotrexate—Urticaria—Prednisone—multiple sclerosis	5.52e-05	0.000218	CcSEcCtD
Methotrexate—Headache—Triamcinolone—multiple sclerosis	5.51e-05	0.000217	CcSEcCtD
Methotrexate—Headache—Methylprednisolone—multiple sclerosis	5.5e-05	0.000217	CcSEcCtD
Methotrexate—Abdominal pain—Prednisone—multiple sclerosis	5.5e-05	0.000217	CcSEcCtD
Methotrexate—Body temperature increased—Prednisone—multiple sclerosis	5.5e-05	0.000217	CcSEcCtD
Methotrexate—Diarrhoea—Dexamethasone—multiple sclerosis	5.46e-05	0.000215	CcSEcCtD
Methotrexate—Diarrhoea—Betamethasone—multiple sclerosis	5.46e-05	0.000215	CcSEcCtD
Methotrexate—Dizziness—Dexamethasone—multiple sclerosis	5.28e-05	0.000208	CcSEcCtD
Methotrexate—Dizziness—Betamethasone—multiple sclerosis	5.28e-05	0.000208	CcSEcCtD
Methotrexate—Nausea—Triamcinolone—multiple sclerosis	5.23e-05	0.000206	CcSEcCtD
Methotrexate—Nausea—Methylprednisolone—multiple sclerosis	5.21e-05	0.000205	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisone—multiple sclerosis	5.12e-05	0.000202	CcSEcCtD
Methotrexate—Vomiting—Betamethasone—multiple sclerosis	5.08e-05	0.0002	CcSEcCtD
Methotrexate—Vomiting—Dexamethasone—multiple sclerosis	5.08e-05	0.0002	CcSEcCtD
Methotrexate—Rash—Dexamethasone—multiple sclerosis	5.03e-05	0.000198	CcSEcCtD
Methotrexate—Rash—Betamethasone—multiple sclerosis	5.03e-05	0.000198	CcSEcCtD
Methotrexate—Dermatitis—Dexamethasone—multiple sclerosis	5.03e-05	0.000198	CcSEcCtD
Methotrexate—Dermatitis—Betamethasone—multiple sclerosis	5.03e-05	0.000198	CcSEcCtD
Methotrexate—Headache—Betamethasone—multiple sclerosis	5e-05	0.000197	CcSEcCtD
Methotrexate—Headache—Dexamethasone—multiple sclerosis	5e-05	0.000197	CcSEcCtD
Methotrexate—Asthenia—Prednisone—multiple sclerosis	4.99e-05	0.000197	CcSEcCtD
Methotrexate—Pruritus—Prednisone—multiple sclerosis	4.92e-05	0.000194	CcSEcCtD
Methotrexate—Diarrhoea—Prednisone—multiple sclerosis	4.76e-05	0.000187	CcSEcCtD
Methotrexate—Nausea—Betamethasone—multiple sclerosis	4.74e-05	0.000187	CcSEcCtD
Methotrexate—Nausea—Dexamethasone—multiple sclerosis	4.74e-05	0.000187	CcSEcCtD
Methotrexate—Dizziness—Prednisone—multiple sclerosis	4.6e-05	0.000181	CcSEcCtD
Methotrexate—Vomiting—Prednisone—multiple sclerosis	4.42e-05	0.000174	CcSEcCtD
Methotrexate—Rash—Prednisone—multiple sclerosis	4.38e-05	0.000173	CcSEcCtD
Methotrexate—Dermatitis—Prednisone—multiple sclerosis	4.38e-05	0.000173	CcSEcCtD
Methotrexate—Headache—Prednisone—multiple sclerosis	4.36e-05	0.000172	CcSEcCtD
Methotrexate—Nausea—Prednisone—multiple sclerosis	4.13e-05	0.000163	CcSEcCtD
Methotrexate—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	3.17e-05	0.000301	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	3.17e-05	0.000301	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.15e-05	0.000299	CbGpPWpGaD
Methotrexate—PGD—Disease—APOE—multiple sclerosis	3.14e-05	0.000299	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD80—multiple sclerosis	3.11e-05	0.000295	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.1e-05	0.000294	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GPC5—multiple sclerosis	3.05e-05	0.00029	CbGpPWpGaD
Methotrexate—FPGS—Disease—CD4—multiple sclerosis	3.04e-05	0.000289	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.02e-05	0.000287	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3e-05	0.000285	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP27B1—multiple sclerosis	2.93e-05	0.000279	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP24A1—multiple sclerosis	2.93e-05	0.000279	CbGpPWpGaD
Methotrexate—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	2.92e-05	0.000277	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GPC5—multiple sclerosis	2.9e-05	0.000275	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ALB—multiple sclerosis	2.89e-05	0.000275	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—ALB—multiple sclerosis	2.89e-05	0.000275	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—BCHE—multiple sclerosis	2.89e-05	0.000274	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.89e-05	0.000274	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—APOE—multiple sclerosis	2.88e-05	0.000273	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.88e-05	0.000273	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.84e-05	0.00027	CbGpPWpGaD
Methotrexate—PGD—Disease—CD80—multiple sclerosis	2.84e-05	0.00027	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—BCHE—multiple sclerosis	2.82e-05	0.000268	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—RRM1—multiple sclerosis	2.81e-05	0.000267	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2RA—multiple sclerosis	2.8e-05	0.000266	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.77e-05	0.000263	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—STAT3—multiple sclerosis	2.77e-05	0.000263	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.76e-05	0.000262	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TNF—multiple sclerosis	2.76e-05	0.000262	CbGpPWpGaD
Methotrexate—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	2.74e-05	0.00026	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.73e-05	0.000259	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ALB—multiple sclerosis	2.71e-05	0.000258	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GPC5—multiple sclerosis	2.68e-05	0.000255	CbGpPWpGaD
Methotrexate—PGD—Metabolism—APOE—multiple sclerosis	2.63e-05	0.00025	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TYK2—multiple sclerosis	2.62e-05	0.000249	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	2.59e-05	0.000246	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—MYC—multiple sclerosis	2.58e-05	0.000245	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SRM—multiple sclerosis	2.57e-05	0.000244	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD86—multiple sclerosis	2.57e-05	0.000244	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—TGFB1—multiple sclerosis	2.57e-05	0.000244	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SELE—multiple sclerosis	2.57e-05	0.000244	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—BCHE—multiple sclerosis	2.56e-05	0.000244	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.53e-05	0.000241	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—RRM1—multiple sclerosis	2.53e-05	0.00024	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—MAPK1—multiple sclerosis	2.52e-05	0.000239	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD86—multiple sclerosis	2.51e-05	0.000238	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.5e-05	0.000238	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.49e-05	0.000237	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.48e-05	0.000236	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—POMC—multiple sclerosis	2.47e-05	0.000235	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.46e-05	0.000233	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.44e-05	0.000231	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.43e-05	0.000231	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.41e-05	0.000229	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.4e-05	0.000228	CbGpPWpGaD
Methotrexate—PGD—Disease—TYK2—multiple sclerosis	2.4e-05	0.000228	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.4e-05	0.000228	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.38e-05	0.000226	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—CD4—multiple sclerosis	2.37e-05	0.000225	CbGpPWpGaD
Methotrexate—ABCC1—Disease—RPL5—multiple sclerosis	2.37e-05	0.000225	CbGpPWpGaD
Methotrexate—FPGS—Disease—STAT3—multiple sclerosis	2.36e-05	0.000224	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.35e-05	0.000223	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—BCHE—multiple sclerosis	2.34e-05	0.000222	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD86—multiple sclerosis	2.28e-05	0.000217	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CCR5—multiple sclerosis	2.28e-05	0.000216	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC11A1—multiple sclerosis	2.27e-05	0.000215	CbGpPWpGaD
Methotrexate—PGD—Metabolism—POMC—multiple sclerosis	2.26e-05	0.000215	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—multiple sclerosis	2.25e-05	0.000214	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SRM—multiple sclerosis	2.25e-05	0.000214	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.24e-05	0.000213	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—BCHE—multiple sclerosis	2.24e-05	0.000213	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—multiple sclerosis	2.23e-05	0.000212	CbGpPWpGaD
Methotrexate—AOX1—Disease—CCR5—multiple sclerosis	2.23e-05	0.000211	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—RRM1—multiple sclerosis	2.22e-05	0.000211	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HLA-A—multiple sclerosis	2.22e-05	0.000211	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.2e-05	0.000209	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—IL2—multiple sclerosis	2.2e-05	0.000209	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.19e-05	0.000208	CbGpPWpGaD
Methotrexate—FPGS—Disease—MYC—multiple sclerosis	2.19e-05	0.000208	CbGpPWpGaD
Methotrexate—FPGS—Disease—TGFB1—multiple sclerosis	2.19e-05	0.000208	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.18e-05	0.000207	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.18e-05	0.000207	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.17e-05	0.000207	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.17e-05	0.000206	CbGpPWpGaD
Methotrexate—PGD—Disease—CD4—multiple sclerosis	2.17e-05	0.000206	CbGpPWpGaD
Methotrexate—AOX1—Disease—HLA-A—multiple sclerosis	2.17e-05	0.000206	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.15e-05	0.000204	CbGpPWpGaD
Methotrexate—FPGS—Disease—MAPK1—multiple sclerosis	2.14e-05	0.000204	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.09e-05	0.000199	CbGpPWpGaD
Methotrexate—MTHFR—Disease—APOE—multiple sclerosis	2.07e-05	0.000197	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.07e-05	0.000196	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—multiple sclerosis	2.06e-05	0.000196	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—BCHE—multiple sclerosis	2.05e-05	0.000195	CbGpPWpGaD
Methotrexate—DHFR—Disease—CCR5—multiple sclerosis	2.03e-05	0.000192	CbGpPWpGaD
Methotrexate—AOX1—Disease—APOE—multiple sclerosis	2.03e-05	0.000192	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—multiple sclerosis	2.02e-05	0.000192	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.99e-05	0.000189	CbGpPWpGaD
Methotrexate—DHFR—Disease—HLA-A—multiple sclerosis	1.97e-05	0.000187	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.96e-05	0.000186	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.96e-05	0.000186	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.95e-05	0.000185	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—multiple sclerosis	1.94e-05	0.000184	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.93e-05	0.000183	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD80—multiple sclerosis	1.87e-05	0.000178	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.87e-05	0.000178	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.86e-05	0.000177	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.86e-05	0.000177	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ITGA4—multiple sclerosis	1.85e-05	0.000176	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—BCHE—multiple sclerosis	1.85e-05	0.000176	CbGpPWpGaD
Methotrexate—DHFR—Disease—APOE—multiple sclerosis	1.84e-05	0.000175	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IFNB1—multiple sclerosis	1.84e-05	0.000175	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—STAT3—multiple sclerosis	1.84e-05	0.000174	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD80—multiple sclerosis	1.83e-05	0.000174	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.83e-05	0.000174	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD28—multiple sclerosis	1.81e-05	0.000172	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP27B1—multiple sclerosis	1.81e-05	0.000172	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP24A1—multiple sclerosis	1.81e-05	0.000172	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—MYC—multiple sclerosis	1.78e-05	0.000169	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.77e-05	0.000168	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.77e-05	0.000168	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.75e-05	0.000166	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—MAPK1—multiple sclerosis	1.74e-05	0.000166	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.74e-05	0.000165	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—APOE—multiple sclerosis	1.74e-05	0.000165	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TGFB1—multiple sclerosis	1.72e-05	0.000163	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.71e-05	0.000162	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MYC—multiple sclerosis	1.71e-05	0.000162	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.7e-05	0.000162	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFB1—multiple sclerosis	1.7e-05	0.000162	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—APOE—multiple sclerosis	1.7e-05	0.000161	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.68e-05	0.00016	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—MAPK1—multiple sclerosis	1.68e-05	0.00016	CbGpPWpGaD
Methotrexate—PGD—Disease—STAT3—multiple sclerosis	1.68e-05	0.00016	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MAPK1—multiple sclerosis	1.67e-05	0.000159	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD80—multiple sclerosis	1.67e-05	0.000158	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GPC5—multiple sclerosis	1.66e-05	0.000157	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—multiple sclerosis	1.65e-05	0.000156	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—IL2—multiple sclerosis	1.64e-05	0.000156	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.62e-05	0.000154	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000153	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.6e-05	0.000152	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.59e-05	0.000151	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.59e-05	0.000151	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TYK2—multiple sclerosis	1.58e-05	0.00015	CbGpPWpGaD
Methotrexate—PGD—Disease—MYC—multiple sclerosis	1.56e-05	0.000148	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—multiple sclerosis	1.56e-05	0.000148	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—MYC—multiple sclerosis	1.56e-05	0.000148	CbGpPWpGaD
Methotrexate—AOX1—Disease—TYK2—multiple sclerosis	1.55e-05	0.000147	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—APOE—multiple sclerosis	1.54e-05	0.000147	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.54e-05	0.000146	CbGpPWpGaD
Methotrexate—PGD—Disease—MAPK1—multiple sclerosis	1.53e-05	0.000145	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.53e-05	0.000145	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—MAPK1—multiple sclerosis	1.52e-05	0.000145	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—POMC—multiple sclerosis	1.49e-05	0.000142	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.48e-05	0.00014	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.46e-05	0.000139	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.46e-05	0.000139	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—POMC—multiple sclerosis	1.46e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—BCHE—multiple sclerosis	1.45e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GPC5—multiple sclerosis	1.45e-05	0.000138	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.44e-05	0.000137	CbGpPWpGaD
Methotrexate—MTHFR—Disease—CD4—multiple sclerosis	1.43e-05	0.000136	CbGpPWpGaD
Methotrexate—DHFR—Disease—TYK2—multiple sclerosis	1.41e-05	0.000134	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—APOE—multiple sclerosis	1.41e-05	0.000134	CbGpPWpGaD
Methotrexate—AOX1—Disease—CD4—multiple sclerosis	1.4e-05	0.000133	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.39e-05	0.000132	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.38e-05	0.000131	CbGpPWpGaD
Methotrexate—ALB—Metabolism—RRM1—multiple sclerosis	1.37e-05	0.00013	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—multiple sclerosis	1.36e-05	0.000129	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—APOE—multiple sclerosis	1.35e-05	0.000128	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—multiple sclerosis	1.33e-05	0.000126	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—POMC—multiple sclerosis	1.33e-05	0.000126	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD86—multiple sclerosis	1.29e-05	0.000123	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.28e-05	0.000122	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—multiple sclerosis	1.28e-05	0.000122	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—multiple sclerosis	1.28e-05	0.000122	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—BCHE—multiple sclerosis	1.28e-05	0.000121	CbGpPWpGaD
Methotrexate—DHFR—Disease—CD4—multiple sclerosis	1.27e-05	0.000121	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2RA—multiple sclerosis	1.27e-05	0.00012	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—MAPK1—multiple sclerosis	1.26e-05	0.000119	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—APOE—multiple sclerosis	1.24e-05	0.000117	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—multiple sclerosis	1.21e-05	0.000115	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—POMC—multiple sclerosis	1.21e-05	0.000115	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—RRM1—multiple sclerosis	1.2e-05	0.000114	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—multiple sclerosis	1.17e-05	0.000111	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—POMC—multiple sclerosis	1.16e-05	0.00011	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CCR5—multiple sclerosis	1.15e-05	0.000109	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.12e-05	0.000107	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HLA-A—multiple sclerosis	1.12e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—APOE—multiple sclerosis	1.11e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.11e-05	0.000105	CbGpPWpGaD
Methotrexate—MTHFR—Disease—STAT3—multiple sclerosis	1.11e-05	0.000105	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.11e-05	0.000105	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.1e-05	0.000105	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—multiple sclerosis	1.1e-05	0.000105	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.09e-05	0.000103	CbGpPWpGaD
Methotrexate—AOX1—Disease—STAT3—multiple sclerosis	1.08e-05	0.000103	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.06e-05	0.000101	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—POMC—multiple sclerosis	1.06e-05	0.000101	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—multiple sclerosis	1.05e-05	0.0001	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOE—multiple sclerosis	1.04e-05	9.91e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.03e-05	9.82e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MYC—multiple sclerosis	1.03e-05	9.78e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—multiple sclerosis	1.03e-05	9.76e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MAPK1—multiple sclerosis	1.01e-05	9.57e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—MYC—multiple sclerosis	1.01e-05	9.55e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—multiple sclerosis	1e-05	9.53e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—STAT3—multiple sclerosis	9.85e-06	9.35e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—MAPK1—multiple sclerosis	9.84e-06	9.35e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOE—multiple sclerosis	9.7e-06	9.22e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—multiple sclerosis	9.67e-06	9.19e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—POMC—multiple sclerosis	9.57e-06	9.09e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD80—multiple sclerosis	9.43e-06	8.96e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MYC—multiple sclerosis	9.15e-06	8.69e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.15e-06	8.69e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—multiple sclerosis	9.13e-06	8.67e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MAPK1—multiple sclerosis	8.95e-06	8.5e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOE—multiple sclerosis	8.73e-06	8.3e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—multiple sclerosis	8.73e-06	8.29e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—POMC—multiple sclerosis	8.34e-06	7.92e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOE—multiple sclerosis	8.3e-06	7.88e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TYK2—multiple sclerosis	7.96e-06	7.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—BCHE—multiple sclerosis	7.88e-06	7.49e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—multiple sclerosis	7.74e-06	7.35e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOE—multiple sclerosis	7.68e-06	7.3e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—multiple sclerosis	7.6e-06	7.22e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—multiple sclerosis	7.56e-06	7.18e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—POMC—multiple sclerosis	7.5e-06	7.13e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IL2—multiple sclerosis	7.43e-06	7.06e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CD4—multiple sclerosis	7.2e-06	6.84e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—POMC—multiple sclerosis	7.13e-06	6.77e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.95e-06	6.6e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—BCHE—multiple sclerosis	6.91e-06	6.56e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—multiple sclerosis	6.88e-06	6.53e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—multiple sclerosis	6.84e-06	6.5e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—POMC—multiple sclerosis	6.6e-06	6.27e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—multiple sclerosis	6.5e-06	6.17e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—multiple sclerosis	6.02e-06	5.72e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—multiple sclerosis	5.79e-06	5.5e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MAPK1—multiple sclerosis	5.68e-06	5.4e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—STAT3—multiple sclerosis	5.57e-06	5.29e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MYC—multiple sclerosis	5.18e-06	4.92e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—multiple sclerosis	5.17e-06	4.91e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MAPK1—multiple sclerosis	5.07e-06	4.81e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOE—multiple sclerosis	4.74e-06	4.5e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOE—multiple sclerosis	4.15e-06	3.95e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—POMC—multiple sclerosis	4.07e-06	3.87e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—multiple sclerosis	3.89e-06	3.7e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—POMC—multiple sclerosis	3.57e-06	3.39e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—multiple sclerosis	3.25e-06	3.09e-05	CbGpPWpGaD
